Tagpharmaceutical companies

It’s time to lift the restrictions on medical abortion in Australia – Professor Caroline de Costa

I

The Conversation, April 1, 2019 6.13am AEDT Over the past thirteen years, many Australian women have used the drug mifepristone (RU486) to bring about a medical abortion. Rather than undergoing a surgical abortion in a clinic or hospital operating theatre, a medical abortion is induced by taking drugs prescribed by a doctor. But while mifepristone has been available in Australia since 2006, only...

Pelvic mesh implant patients want answers from Senate report

P

ABC 730 report, 26/3/2018 A steady stream of Australian women with pelvic mesh implants have spent tens of thousands of dollars flying to a clinic in Missouri to have their implants removed, claiming they have suffered major side-effects from the implants used to treat prolapse and incontinence. More than 35 Australian women have made the journey to the same practitioner because, they say, they...

Essure contraceptive device: Hazard Alert from TGA

E

Therapeutic Goods Administration, August 30, 2017
Consumers and health professionals are advised that Australasian Medical and Science Ltd (AMSL), in consultation with the TGA, has issued a hazard alert for Essure. AMSL is also recallingunused stock and withdrawing the device from the Australian market.

Read more of Essure contraceptive device: Hazard Alert

New class of antibiotic raises hopes for urgently-needed gonorrhoea drug

N

The Guardian, Tuesday 8 August 2017 03.00 AEST A new class of antibiotic has been found to work in the lab against the sexually transmitted infection gonorrhoea, which can cause infertility and damage to babies and is fast becoming resistant to all existing drugs. Although it is early days, because the antibiotic has yet to be tried in animals or humans, researchers say they are excited by its...

The battle over Essure

T

The Washington Post, Published on July 26, 2017 Nobody can say exactly how many women have had Essure implanted since the device went on the market in 2002. Bayer, which is headquartered in Germany, says that more than 750,000 devices have been sold worldwide and that sales “continue to grow.”  In recent years, the [US] Food and Drug Administration has received more than 16,000 adverse-event...

Early warning system exposes the rise of the gonorrhoea ‘super-superbug’

E

The Age, July19th 2017 – 8:32 AM A critically drug-resistant strain of gonorrhoea dubbed a “super-superbug” has been detected in every Australian state and territory by a new national surveillance system. The National Alert System for Critical Antimicrobial Resistance (CARAlert) identified 1,064 bacteria highly resistant to last-line antibiotics between 17 March 2016 and 31...

Your sidebar area is currently empty. Hurry up and add some widgets.